Dozens of attorneys general from across the U.S., including Kentucky's Jack Conway, are asking the U.S. Food and Drug Administration to require makers of generic prescription pain relievers to make tamper-resistant versions of their products.
The attorneys general thanked the FDA for its efforts to require abuse-deterrent formulations for branded opioids and urged the agency to make sure generic versions have those properties as well.
Conway says abuse deterrence for generics offers another way to try to battle a problem that affects families all around the state. Conway and 41 other attorneys general sent the letter yesterday.